Emergent BioSolutions (EBS) Change in Cash (2010 - 2026)

Emergent BioSolutions' Change in Cash history runs 17 years deep, the most recent figure standing at -$47.6 million for Q1 2026.

• In Q1 2026, Change in Cash fell 200.85% year-over-year to -$47.6 million; the TTM figure through Mar 2026 stood at $8.7 million (down 88.21% YoY), while the FY2025 annual figure was $103.5 million, up 1796.72% from the prior year.
• Change in Cash was -$47.6 million for Q1 2026 at Emergent BioSolutions, down from -$40.1 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $401.6 million in Q4 2022 to a low of -$344.2 million in Q2 2023.
• Historically, Change in Cash has averaged -$24.4 million across 5 years, with a median of -$32.7 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Change in Cash plunged 342.99% in 2023, then jumped 10775.0% in 2024.
• A 5-year view of Change in Cash shows it stood at $401.6 million in 2022, then tumbled by 94.05% to $23.9 million in 2023, then tumbled by 312.55% to -$50.8 million in 2024, then increased by 21.06% to -$40.1 million in 2025, then fell by 18.7% to -$47.6 million in 2026.
• The last three Change in Cash figures came in at -$47.6 million (Q1 2026), -$40.1 million (Q4 2025), and -$21.8 million (Q3 2025), per Business Quant data.